• LAST PRICE
    290.9700
  • TODAY'S CHANGE (%)
    Trending Up14.4200 (5.2142%)
  • Bid / Lots
    290.3600/ 3
  • Ask / Lots
    291.0300/ 1
  • Open / Previous Close
    278.8800 / 276.5500
  • Day Range
    Low 277.4800
    High 292.0700
  • 52 Week Range
    Low 119.7604
    High 299.9800
  • Volume
    270,759
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 276.55
TimeVolumeMDGL
09:32 ET5070278
09:36 ET100279.08
09:38 ET100280.86
09:43 ET1916277.48
09:45 ET100278.35
09:48 ET7603278.4125
09:50 ET5899279.295
09:52 ET200280.9799
09:54 ET140279.4
09:56 ET2300279.4
09:59 ET900280.055
10:01 ET3277280.98
10:03 ET822281.49
10:06 ET1123282.66
10:08 ET589283
10:10 ET360282.665
10:12 ET1070283.9
10:14 ET4768283.5675
10:15 ET100283.635
10:17 ET200283.67
10:21 ET1750284.98
10:24 ET5293285.31
10:26 ET959284.94
10:28 ET400284.105
10:30 ET100284.14
10:33 ET300284.53
10:39 ET150284.7424
10:42 ET2920284.39
10:44 ET1400285.39
10:46 ET2402286.37
10:48 ET507286.5118
10:50 ET1598287.85
10:51 ET650288.8025
10:53 ET2402289.1
10:55 ET795289.27
10:57 ET200289.17
11:00 ET300289.93
11:04 ET500289.155
11:06 ET100289.93
11:08 ET3828290.13
11:09 ET300289.86
11:11 ET500290.59
11:13 ET400289.82
11:15 ET811290.485
11:18 ET628290.59
11:22 ET550290.385
11:26 ET102290.36
11:27 ET100289.78
11:29 ET100289.37
11:31 ET200289.43
11:33 ET661289
11:36 ET575287.71
11:38 ET630287.59
11:40 ET391287.1618
11:42 ET100286.84
11:45 ET600287.22
11:49 ET108286.22
11:51 ET100286.635
11:54 ET2904286.39
11:56 ET100285.3514
11:58 ET634285.37
12:00 ET330285.415
12:02 ET100285.74
12:03 ET227285.74
12:05 ET200285.9582
12:09 ET1200286.67
12:12 ET237286.218
12:16 ET100286.73
12:21 ET100287.25
12:27 ET200288.71
12:30 ET300288.8899
12:36 ET600288.942
12:38 ET425289.42
12:39 ET600289.4699
12:41 ET804289.12
12:43 ET476289.46
12:45 ET100289
12:48 ET100289.55
12:50 ET303289.66
12:52 ET300289.33
12:54 ET500290.39
12:56 ET700290.09
12:59 ET537289.14
01:06 ET100288.6
01:12 ET100288.21
01:14 ET100288.44
01:19 ET300288.285
01:28 ET100289.1
01:32 ET100289.33
01:35 ET100289.305
01:37 ET300289.565
01:39 ET100289.8
01:44 ET100289.52
01:46 ET200289.51
01:50 ET185290.04
01:51 ET613290.235
01:53 ET300290.445
01:55 ET3446291.15
01:57 ET2805290.76
02:02 ET110290.25
02:04 ET200290.62
02:08 ET400291
02:09 ET355291.43
02:11 ET100291.43
02:13 ET1191291.4892
02:20 ET3050291.55
02:22 ET100291.1028
02:27 ET400290.23
02:31 ET400290.11
02:33 ET200289.41
02:36 ET100290.055
02:42 ET300290.38
02:44 ET200290.41
02:45 ET200290.1
02:47 ET300290.025
02:49 ET100289.96
02:51 ET713289.83
02:54 ET100289.705
02:56 ET225289.01
02:58 ET300289.2175
03:00 ET100289.86
03:02 ET175289.5598
03:03 ET1633290.23
03:05 ET1334290.37
03:09 ET300290.38
03:12 ET350290.08
03:14 ET100290.3
03:16 ET500289.77
03:20 ET1223288.71
03:21 ET2347288.665
03:25 ET100289.955
03:27 ET259289.965
03:30 ET400289.29
03:32 ET300289.97
03:34 ET250290.4399
03:36 ET4631287.85
03:38 ET975286.52
03:39 ET300286.05
03:41 ET1500285.725
03:43 ET300285.565
03:45 ET2500287.245
03:48 ET372287.63
03:50 ET1400286.65
03:52 ET2679287.465
03:54 ET1500288.43
03:56 ET9909290.575
03:57 ET4307290.97
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMDGL
Madrigal Pharmaceuticals Inc
5.9B
-12.6x
---
United StatesVKTX
Viking Therapeutics Inc
5.7B
-54.7x
---
United StatesRVMD
Revolution Medicines Inc
6.2B
-10.5x
---
United StatesCYTK
Cytokinetics Inc
6.4B
-10.5x
---
United StatesSMMT
Summit Therapeutics Inc
5.1B
-45.3x
---
United StatesKRYS
Krystal Biotech Inc
5.3B
101.4x
---
As of 2024-07-08

Company Information

Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directed thyroid hormone receptor-β (THR-β) agonist designed to target key underlying causes of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). The Company’s clinical development program includes MAESTRO-NASH, MAESTRO-NAFLD-1, and MAESTRO-NASH OUTCOMES.

Contact Information

Headquarters
200 Barr Harbor Dr Ste 400WEST CONSHOHOCKEN, PA, United States 19428-2978
Phone
404-380-9263
Fax
302-655-5049

Executives

Independent Chairman of the Board
Julian Baker
President, Chief Executive Officer, Director
Bill Sibold
Chief Financial Officer, Senior Vice President
Mardi Dier
President of Research and Development, Chief Medical Officer, Director
Rebecca Taub
Chief Commercial Officer
Carole Huntsman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$5.9B
Revenue (TTM)
$0.00
Shares Outstanding
21.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
-0.43
EPS
$-23.08
Book Value
$20.39
P/E Ratio
-12.6x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.